Tj Cradick

Chief Scientific Officer (CSO) at Excision BioTherapeutics in July 2020 to March 2024

Strategic Advisor at Gene Editing Frontiers LLC in January 2020 to February 2021

Head of Genome Editing at CRISPR Therapeutics in March 2015 to November 2019

Director of Protein Engineering Facility at Georgia Institute of Technology in April 2011 to March 2015

Biotech / Patent Consultant at Biotechnology Consulting in January 2010 to January 2011

Co-owner, Scientific Advisor at Protein Delivery Startup in January 2009 to January 2010

Postdoctoral Fellow, Zinc Finger Nuclease Design & Testing at University of Iowa in January 2009 to January 2010

PhD Student to Post Doc, Zinc Finger Nuclease Design, Testing and Development at University of Iowa in January 2004 to January 2009

Associate Scientist II, Zinc Finger Design & Selection Group at Sangamo BioSciences in January 2000 to January 2004

Phage Display for High-Throughput Screening at Tularik in January 1998 to January 1999

PhD Student in Immunology and Microbiology, Developing Proteolytic Antibodies at University of California, San Francisco in January 1993 to January 1998

Immunology Consultant for Law Firm at Ropers, Majeski, Kohn & Bentley in January 1996 to January 1996

Research Associate, HIV Reseach, Phage Display & Drug Discovery at Repligen Corporation in January 1989 to January 1993

Research Associate, Diabetes Research, Molecular Biology Lab at Joslin Diabetes Center in January 1988 to January 1989

Campus Tour Guide at MIT in January 1985 to January 1988

UROP Undergraduate Researcher at MIT in January 1986 to January 1986

Massachusetts Institute of Technology, BS, January 1984 to January 1988

Marist High School, Atlanta GA, January 1980 to January 1984